JacobsI.J.SkatesS.J.MacdonaldN.MenonU.RosenthalA.DaviesA.P.WoolasR.JeyarajahA.SibleyK.OramD.H.Screening for ovarian cancer: a pilot randomised controlled trial. Lancet1999; 353: 1207–10.
2.
SkatesSPaulerDJacobsI. (2001). Screening based on the risk of cancer calculation from Bayesian hierarchical change-point and mixture models of longitudinal markers. Journal of American Statistical Association; 96 (454):429–439.
3.
MenonUTalaatARosenthalAN. Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening. BJOG107 (2): 165–9.2000.
4.
MenonUJacobsIJ. (2000). Ovarian cancer screening in the general populationUltrasound Obstet Gynecol2000; 15: 350–3.
5.
KurjakAKupesicSSparacVKosutaD. Three-dimensional ultrasonographic and power Doppler characterization of ovarian lesions. Ultrasound Obstet Gynecol.16 (4), 365–71 (2000).
6.
CohenLSEscobarPFScharmCGlimcoBFishmanDA. Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction. Gynecol Oncol.82 (2), 40–8 (2001).
7.
KehoeSLoweDPowellJEVincenteB. Artificial neural networks and survival prediction in ovarian carcinoma. Eur J Gynaecol Oncol.21 (6), 583–4 (2000).
8.
TailorAJurkovicDBourneTHCollinsWPCampbellS. Sonographic prediction of malignancy in adnexal masses using an artificial neural network. Br J Obstet Gynaecol.106 (2), 21–30 (1999).
9.
ClaytonRDSnowdenSWestonMJMogensenOEastaughJLaneG. Neural networks in the diagnosis of malignant ovarian tumours. Br J Obstel Gynaecol, 106 (10), 1078–82 (1999).
10.
GohaganJKProrokPCHayesRBKramerBS. The Prostate. Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials2000; 21:(6 Suppl): 251S–272S.
